TY - JOUR
T1 - Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs
AU - Kronborg, G
AU - Hansen, M B
AU - Svenson, M
AU - Fomsgaard, A
AU - Høiby, N
AU - Bendtzen, K
PY - 1993/5
Y1 - 1993/5
N2 - The presence of interleukin (IL)-1 receptor antagonist (IRAP) in plasma and sputum from patients with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa lung infection was investigated together with IL-1 alpha, IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF) in a cross-sectional study. All cytokines were assayed by ELISAs. High concentrations of IRAP, IL-1 alpha, IL-1 beta, IL-6, and TNF in sputum samples and low or nondetectable levels of circulating cytokines were frequently found. Increased concentrations of plasma IRAP are positively correlated with decreasing pulmonary function. In a longitudinal study of serum IRAP, a higher level of IRAP was detected in a group of patients with poor pulmonary function compared to a group with good pulmonary function.
AB - The presence of interleukin (IL)-1 receptor antagonist (IRAP) in plasma and sputum from patients with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa lung infection was investigated together with IL-1 alpha, IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF) in a cross-sectional study. All cytokines were assayed by ELISAs. High concentrations of IRAP, IL-1 alpha, IL-1 beta, IL-6, and TNF in sputum samples and low or nondetectable levels of circulating cytokines were frequently found. Increased concentrations of plasma IRAP are positively correlated with decreasing pulmonary function. In a longitudinal study of serum IRAP, a higher level of IRAP was detected in a group of patients with poor pulmonary function compared to a group with good pulmonary function.
KW - Adolescent
KW - Adult
KW - Chronic Disease
KW - Cross-Sectional Studies
KW - Cystic Fibrosis/complications
KW - Female
KW - Forced Expiratory Volume
KW - Humans
KW - Inflammation
KW - Interleukin 1 Receptor Antagonist Protein
KW - Interleukin-1/analysis
KW - Interleukin-6/analysis
KW - Interleukins/analysis
KW - Longitudinal Studies
KW - Lung/pathology
KW - Male
KW - Pseudomonas Infections/complications
KW - Respiratory Tract Infections/complications
KW - Sialoglycoproteins/analysis
KW - Sputum/immunology
KW - Tumor Necrosis Factor-alpha/analysis
KW - Vital Capacity
U2 - 10.1002/ppul.1950150506
DO - 10.1002/ppul.1950150506
M3 - Journal article
C2 - 8327288
SN - 8755-6863
VL - 15
SP - 292
EP - 297
JO - Pediatric Pulmonology
JF - Pediatric Pulmonology
IS - 5
ER -